Abstract :
Osteoporosis, and the fractures that result from it, are a global public health issue. The management of osteoporosis has undergone significant changes in the past decades. However, its management is marked by wide disparity, and major differences, across the world. Though the gold standard for diagnosis is bone mineral density (BMD), performed by dual energy X-ray absorptiometry (DEXA),1 this investigation is inaccessible to patients in many parts of the world. A better tool, however, has been available since 2008, to compute the fracture probability or risk.
